The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 26,801–26,900 of 31,469
Takeuchi, M., Tsuboi, A., Kurata, M., Fukuo, K., & Kazumi, T. (2015) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2015.0014 · Cited by 2
Impact of hypoalphalipoproteinemia on quality of life in Taiwanese women with central obesity
Chen, I.-J., Lin, W.-C., Liu, C.-Y., et al. (2013) · Quality of Life Research · doi:10.1007/s11136-013-0601-8 · Cited by 2
Öztaş, E., Çağlar, G. S., Kaya, C., Karadağ, D., Demırtaş, S., Kurt, M., & Pabuçcu, R. (2014) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2014.09.037 · Cited by 2
RetractedAssociation between Smoking Status and Insulin Resistance in Apparently Healthy Korean Men
Kim, H. J., Kim, J.-S., & Yoo, J.-H. (2009) · Korean Journal of Family Medicine · doi:10.4082/kjfm.2009.30.3.190 · Cited by 2
Liu, L.-K., Liu, C., Peng, L., Chen, L.-Y., Su, C.-T., Ming-hsien, L., & Chen, L.-K. (2014) · Journal of Clinical Gerontology and Geriatrics · doi:10.1016/j.jcgg.2014.01.003 · Cited by 2
You, M., Kim, M.-S., Rhyu, D. Y., & Kim, H. (2013) · Korean Journal of Food Preservation · doi:10.11002/kjfp.2013.20.1.1 · Cited by 2
Calcium-stimulation test for the assessment of β-cell function in cats
Slingerland, L. I., Rijnberk, A., & Kooistra, H. S. (2007) · Research in Veterinary Science · doi:10.1016/j.rvsc.2007.05.021 · Cited by 2
Adiponectin in Members of Families With Familial Combined Hyperlipidemia
Karásek, D., Vaverková, H., Halenka, M., Jackuliaková, D., Fryšák, Z., & Novotný, D. (2010) · The Endocrinologist · doi:10.1097/ten.0b013e3181de5c22 · Cited by 2
Than, M. M., Thazin, M., & Latt, T. S. (2013) · Journal of the ASEAN Federation of Endocrine Societies · doi:10.15605/jafes.028.01.12 · Cited by 2
Colorectal adenomas and diabetes: implications for disease prevention
Steele, R. J., Anderson, A. S., Macleod, M., et al. (2015) · Colorectal Disease · doi:10.1111/codi.12895 · Cited by 2
Elkind-Hirsch, K. E., Ogden, B. W., Darensbourg, C., & Schelin, B. L. (2010) · International Journal of Diabetes Mellitus · doi:10.1016/j.ijdm.2009.12.006 · Cited by 2
Wasada, T., Kuroki, H., ARII, H., Satô, A., Katsumori, K., Saito, S., & Iwamoto, Y. (2000) · Endocrine Journal · doi:10.1507/endocrj.47.309 · Cited by 2
Association of nonalcoholic fatty liver disease with metabolic syndrome in Indian population
Girija, S. M., & Sarin, S. K. (2011) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2012.02.015 · Cited by 2
Niepolski, L., Grzegorzewska, A. E., & Młot-Michalska, M. (2009) · International Urology and Nephrology · doi:10.1007/s11255-009-9525-1 · Cited by 3
Differential patterns of regional neuroadrenergic cardiovascular drive in acromegalic disease
Seravalle, G., Carzaniga, C., Sciortino, G., Attanasio, R., Fatti, L. M., Cozzi, R. C., Montini, M., Vitale, G., Brambilla, G., Cavagnini, F., et al. (2013) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12082 · Cited by 3
Effect of nateglinide on the size of LDL particles in patients with type 2 diabetes
Onishi, Y., Fujisawa, T., Sakaguchi, K., & Maeda, M. (2006) · Advances in Therapy · doi:10.1007/bf02850044 · Cited by 2
Longo‐Mbenza, B., Mvindu, H. N., Phanzu, B. K., On'kin, J. B. K. L., Bikuku, H. N., & Okwe, A. N. (2010) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2010.01.003 · Cited by 2
Okada, T., Iwashina, M., Kasatani, T., Kanno, H., Masanori, Y., Morikawa, K., Uto, H., Yoshida, H., & Asano, A. (2013) · Diabetology International · doi:10.1007/s13340-013-0114-2 · Cited by 2
Savastano, S., Valentino, R., Pizza, G., Rosa, A. D., Orio, F., Passaretti, F., Formisano, P., Lombardi, G., Beguinot, F., & Colao, A. (2010) · Journal of Endocrinological Investigation · doi:10.1007/bf03346622 · Cited by 2
Investigation of impaired carbohydrate metabolism in pediatric liver transplant recipients
Gökçe, S., Durmaz, Ö., Çeltık, C., et al. (2008) · Pediatric Transplantation · doi:10.1111/j.1399-3046.2008.01076.x · Cited by 2
Kang, J., Sung, S. H., Lee, Y. J., Choi, T., & Choi, S. J. (2014) · Journal of Korean Medical Science · doi:10.3346/jkms.2014.29.10.1353 · Cited by 2
Healthy excessive weight in Portuguese women 4years after delivery of a liveborn
Henriques, A., Santos, A. C., Guimarães, J. T., Barros, H., & Azevedo, A. (2015) · Preventive Medicine · doi:10.1016/j.ypmed.2015.03.009 · Cited by 2
Chen, J., Nittala, A., Gao, S., Ghosh, S., Wang, X., & Patel, S. B. (2010) · Islets · doi:10.4161/isl.2.1.9965 · Cited by 2
Insulin Resistance and Cognitive Functions in a Sample of Prefrail, Frail and Non-Frail Elderly
Amer, M. S., Khater, M. S., Adly, N. N., & Maraghy, M. O. E. (2014) · Advances in Aging Research · doi:10.4236/aar.2014.32026 · Cited by 2
Masajtis‐Zagajewska, A., Kurnatowska, I., Wajdlich, M. J., Jagodzińska, M., & Nowicki, M. P. (2013) · International Urology and Nephrology · doi:10.1007/s11255-013-0457-4 · Cited by 2
Chandrakanth, M. V., Das, S., Rout, S. B., et al. (2012) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2012.22033 · Cited by 2
Bando, Y., Ishikura, K., Kanehara, H., Aoki, K., Hisada, A., Toya, D., & Tanaka, N. (2013) · Diabetology International · doi:10.1007/s13340-013-0124-0 · Cited by 2
Saraç, F., Savaş, S., Sarac, S., & Akçiçek, F. (2014) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2014.43034 · Cited by 3
Manzato, E., della Rovere, G. R., Avogaro, A., Zambon, S., Romanato, G., Corti, M. C., Sartori, L., Baggio, G., & Crepaldi, G. (2002) · Aging Clinical and Experimental Research · doi:10.1007/bf03327347 · Cited by 2
Serum calcitonin gene-related peptide levels in women with polycystic ovary syndrome
Fenkçi, S. M., Fenkçi, V., Öztekin, Ö., et al. (2012) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-012-2689-4 · Cited by 2
Vieira, C. S., Gomes, M. K. O., Rodrigues, P. C., Pinto, A. P. M., dos Reis, R. M., Ferriani, R. A., & de Sá, M. F. S. (2007) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1590/s0100-72032007000300005 · Cited by 2
Coniglio, R. I., Etchepare, C., Vásquez, L. A., Colombo, O., Sellés, J., Salgueiro, A. M., Otero, J. C. S., Malaspina, M., Daruiz, J., & Dahinten, E. (2001) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/s0214-9168(01)78764-5 · Cited by 2
Cribado de la enfermedad hepática por depósito de grasa: cómo y a quién
Lantarón, Á. T., & García, J. C. (2011) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2010.11.010 · Cited by 2
Benedini, S., Caumo, A., Terruzzi, L., & Luzi, L. (2013) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2013.33024 · Cited by 2
Barghash, A., Sultan, I. E., Nozha, O. M. A., et al. (2014) · Journal of Taibah University Medical Sciences · doi:10.1016/j.jtumed.2013.12.004 · Cited by 2
Mihai, A. D., Zetu, C., Carniciu, S., Picu, A. A., Petcu, L. M., Guja, C., Lixandru, D., & Ionescu-Tirgoviste, C. (2014) · Romanian Journal of Diabetes Nutrition and Metabolic Diseases · doi:10.2478/rjdnmd-2014-0024 · Cited by 2
Tsekouras, Y., Magkos, F., Kavouras, S. A., Panagiotakos, D. B., & Sidossis, L. S. (2008) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2008.01999.x · Cited by 2
Prevalence of Insulin Resistance in Siblings of Type 2 Diabetics of North West Punjabi Population
Kaur, S. (2014) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2014/10198.4701 · Cited by 2
Relationship between the body iodine status and menopausal symptoms during postmenopausal period
Korkmaz, V., Özkaya, E., Çekmez, Y., Leblebıcı, D., Dağdeviren, G., Çınar, M., Kara, F., & Küçüközkan, T. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2014.958986 · Cited by 2
Lugli, A. K., Donatelli, F., Schricker, T., Wykes, L., & Carli, F. (2011) · Nutrition and Cancer · doi:10.1080/01635581.2011.587228 · Cited by 2
Overview of Cellular Transplantation in Diabetes Mellitus: Focus on the Metabolic Outcome
Luzi, L., Benedini, S., Caumo, A., & Terruzzi, I. M. (2015) · Advances in Endocrinology · doi:10.1155/2015/967562 · Cited by 2
Use of the insulin sensitivity index obtained from oral glucose tolerance test in Japanese subjects
Taniguchi, T., Okamoto, M., Ueno, H., et al. (2001) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(01)00279-0 · Cited by 2
Takai, T., Sakura, H., Uchigata, Y., & Iwamoto, Y. (2012) · Diabetology International · doi:10.1007/s13340-011-0064-5 · Cited by 2
Diagnosing insulin resistance—a clarification
GLASS, K. B., & Czikk, M. J. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.11.017 · Cited by 2
Holzinger, U., Zauner, A., Nimmerrichter, P., et al. (2004) · Wiener klinische Wochenschrift · doi:10.1007/s00508-004-0236-4 · Cited by 2
Periodontal Study on Patients with Type 2 Diabetes Mellitus
Sugihara, K. (2005) · 日本歯周病学会会誌 · doi:10.2329/perio.47.178 · Cited by 2
Tziolas, I. M., Pikilidou, M. I., Zebekakis, P. E., et al. (2008) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2008.10.002 · Cited by 2
Is the severity of obstructive sleep apnoea associated with the degree of insulin resistance?
Nagai, Y., Nakatsumi, Y., Abe, T., & Nomura, G. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00817_2.x · Cited by 2
Refaie, W., & Elewa, A. M. (2013) · The Egyptian Heart Journal · doi:10.1016/j.ehj.2013.02.004 · Cited by 2
Serum Levels of Adipocyte Fatty Acid–Binding Protein Are Decreased in Chronic Pancreatitis
Selig, L., Reiche, M., Ebert, T., Krehl, D., Kralisch, S., Lössner, U., Stach, B., Blüher, M., Stümvoll, M., Bödeker, H., et al. (2012) · Pancreas · doi:10.1097/mpa.0b013e31824e2d93 · Cited by 2
Snogdal, L. S., Grarup, N., Banasik, K., Wod, M., Jørgensen, T., Witte, D. R., Lauritzen, T., Nielsen, A. A., Brandslund, I., Christensen, C., et al. (2013) · BMC Medical Genetics · doi:10.1186/1471-2350-14-113 · Cited by 2
Barbieri, D. E., Ribeiro‐Filho, F. F., Ribeiro, A. B., & Zanella, M. T. (2009) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2009.00164.x · Cited by 2
Vos, R. C., Houdijk, E. C. A. M., van der Kamp, H. J., Pijl, H., & Wit, J. M. (2011) · Hormone Research in Paediatrics · doi:10.1159/000327371 · Cited by 2
Okamoto, A., Yokokawa, H., & Sanada, H. (2014) · Drugs in R&D · doi:10.1007/s40268-014-0062-8 · Cited by 2
Derosa, G., Cicero, A. F. G., D’Angelo, A., Tinelli, C., Ciccarelli, L., Piccinni, M. N., PRICOLO, F., SALVADEO, S. A. T., Montagna, L., Fogari, E., et al. (2006) · High Blood Pressure & Cardiovascular Prevention · doi:10.2165/00151642-200613020-00002 · Cited by 2
Limei, L. I., Ikenishi, R., Iwamoto, M., et al. (2008) · JOURNAL OF THE JAPANESE ASSOCIATION OF RURAL MEDICINE · doi:10.2185/jjrm.56.852 · Cited by 2
Interleukin-6 gene promoter –174G/C polymorphism and insulin resistance: a pilot study
Tretjakovs, P., Latkovskis, G., Licis, N., Juhnēviča, D., Jurka, A., Bormane, I., Aivars, J. I., Stifts, A., & Pīrāgs, V. (2007) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2007.260 · Cited by 2
Lee, S.-S., & So, Y.-S. (2012) · Journal of Life Science · doi:10.5352/jls.2012.22.6.744 · Cited by 2
Hormone replacement therapy and serum uric acid
Sumino, H., Ichikawa, S., Kanda, T., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(05)77129-4 · Cited by 2
Adipotsitokiny: rezistin i faktor nekroza opukholey-α u muzhchin s abdominal'nym ozhireniem
Butrova, S. A., Ershova, E. V., & Ильин, А. В. (2007) · Obesity and metabolism · doi:10.14341/2071-8713-5003 · Cited by 2
Lin, C.-M., Warram, J. H., & Veng‐Pedersen, P. (2011) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-011-9208-2 · Cited by 2
Lee, Y. M., Chung, H. K., Kimm, H., & Jee, S. H. (2012) · 대한지역사회영양학회지 · doi:10.5720/kjcn.2012.17.2.243 · Cited by 2
Deng, H., Hong, D., Li, Y., Su, Z., Ma, H., & Du, M. (2012) · Hormone Research in Paediatrics · doi:10.1159/000343149 · Cited by 2
Sartoretto, J. L., de Melo, G. D. A. N., Bersani‐Amado, C. A., et al. (2008) · Inflammation Research · doi:10.1007/s00011-008-7211-x · Cited by 2
Gupta, M., Braga, M., & Verma, S. (2008) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(08)70685-8 · Cited by 2
Profiles of atherosclerotic risk factors in gastrectomized men
Murai, J., Koga, M., Saito, H., Mukai, M., Matsumoto, S., & Kasayama, S. (2011) · Endocrine Journal · doi:10.1507/endocrj.k10e-401 · Cited by 2
Özerkan, F., Özdoğan, Ö., Zoghi, M., Nalbantgil, S., Yavuzgil, O., & Önder, M. R. (2006) · Current Therapeutic Research · doi:10.1016/j.curtheres.2006.02.002 · Cited by 2
Aerobic and Resistance Training for Patients With Type 2 Diabetes
Lin, G. (2011) · JAMA · doi:10.1001/jama.2011.226 · Cited by 2
[Telmisartan effect's on remodelling bone markers in hypertensive patients].
Pérez‐Castrillón, J. L., de Luis, D. A., Inglada, L., Martínez, J., Pinacho, F., Conde, R., Sagrado, M. G., & Dueñas‐Laita, A. (2012) · PubMed · doi:10.3305/nh.2012.27.1.5416 · Cited by 6
Lipocalin-2: Response to a short-term treadmill protocol in obese and normal-weight men
Damirchi, A., Rahmani‐Nia, F., & Mehrabani, J. (2011) · Journal of Human Sport and Exercise · doi:10.4100/jhse.2011.61.07 · Cited by 2
Insulin and the Physiology of Carbohydrate Metabolism
Pereira, S., & Giacca, A. (2011) · Energy balance and cancer · doi:10.1007/978-1-4419-9911-5_1 · Cited by 3
Carneiro, J. R. I., & da Cruz, G. G. (2012) · Journal of Obesity & Weight loss Therapy · doi:10.4172/2165-7904.1000124 · Cited by 2
Impaired glucose oxidation and glucose‐induced thermogenesis in renal transplant recipients
Pascale, E. D., Giordano, M., Carone, M., et al. (2000) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/15.10.1658 · Cited by 2
Acute and Chronic Effects of Glyceryl Trinitrate Therapy on Insulin and Glucose Regulation in Humans
Jedrzkiewicz, S., & Parker, J. D. (2012) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248412467693 · Cited by 2
Specific insulin and proinsulin in normal glucose tolerant first-degree relatives of NIDDM patients
Coifman, R., Dalbosco, I. S., Russo, E. M., & Moisés, R. S. (1999) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x1999000100010 · Cited by 2
Prevalence of Metabolic Syndrome in Type 2 DM Patients with Non-alcoholic Fatty Liver
Kim, J. M., Park, J. Y., Nam, H. K., et al. (2006) · The Journal of Korean Diabetes Association · doi:10.4093/jkda.2006.30.6.442 · Cited by 2
Yamada, Y., Noborisaka, Y., Ishizaki, M., Tsuritani, I., & Honda, R. (2004) · Environmental Health and Preventive Medicine · doi:10.1007/bf02898137 · Cited by 2
Appetite-related hormone levels in obese women with and without binge eating behavior
Brandão, P. P., Garcia‐Souza, É. P., Neves, F. A., Pereira, M. J. D. S., Sichieri, R., & Moura, A. S. (2011) · Revista de Nutrição · doi:10.1590/s1415-52732011000500001 · Cited by 2
Punjabi, P., Mathur, P., Gupta, R. C., Mathur, I., Thanvi, J., Gupta, D., & Mathur, S. K. (2014) · Journal of Basic & Applied Sciences · doi:10.6000/1927-5129.2014.10.29 · Cited by 2
Elsamanoudy (2010) · American journal of biochemistry & biotechnology/American journal of biochemistry and biotechnology · doi:10.3844/ajbbsp.2010.172.180 · Cited by 2
Kim, H.-J., Byun, E. K., Oh, J. Y., Sung, Y., & Chung, H. (2006) · The Journal of Korean Diabetes Association · doi:10.4093/jkda.2006.30.4.277 · Cited by 2
Vitai, M., Buday, B., Kulcsár, E., Literáti-Nagy, B., Vecsei, I., Bezzegh, K., Péterfai, É., Kurucz, I., & Koranyi, L. I. (2009) · Orvosi Hetilap · doi:10.1556/oh.2009.28729 · Cited by 2
Susceptibility to insulin resistance in indigenous Australians may be down stream of resistin.
Good, D. M., Cardinal, J. W., Ware, R. S., Marks, L. H., Kesting, J. B., Chan, L. C. K., & Shaw, J. T. E. (2019) · International Journal of Diabetes and Metabolism · doi:10.1159/000497645 · Cited by 2
Matsumoto, M., Tsujino, T., Naito, Y., Sakoda, T., Ohyanagi, M., Nonaka, H., & Masuyama, T. (2009) · Clinical and Experimental Hypertension · doi:10.1080/10641960902822526 · Cited by 2
An Appreciation of Robert Turner
O’Rahilly, S., Weir, G. C., & Matthews, D. R. (2008) · Diabetes · doi:10.2337/db07-1644 · Cited by 2
Self-citationKim, M. K., Lee, I. S., Jang, H. W., Joung, K. H., Kim, K. S., Kim, H. J., Lee, T. Y., Kim, Y. K., & Ku, B. J. (2011) · The Korean Journal of Obesity · doi:10.7570/kjo.2011.20.2.75 · Cited by 2
Χούσος, Η., Perrea, D. N., Kyriaki, D., et al. (2010) · Diabetes and Vascular Disease Research · doi:10.1177/1479164110369687 · Cited by 2
Vyssoulis, G. P., Liakos, C. I., Karpanou, E. A., Triantafyllou, A. I., Michaelides, A. P., Tzamou, V., Markou, M. I., & Stefanadis, C. (2013) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2013.02.007 · Cited by 2
L’hyperglycémie provoquée par voie orale (HGPO) revisitée
Scheen, A. J., & Luyckx, F. (2010) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(10)70124-3 · Cited by 2
Ramezani, A., Tahbaz, F., Rasouli, S., Nistani, T., Rashidkhani, B., & Hedayati, M. (2010) · Cited by 2
Association between Apolipoprotein E Polymorphism and Type 2 Diabetes in Subjects Aged 65 or Over
Lee, Y. J., Jang, H. C., Kim, E. H., Kim, H. J., Lee, S. B., Choi, S. H., Lim, S. K., Park, K. U., Park, Y. J., & Kim, K. W. (2008) · Korean Diabetes Journal · doi:10.4093/kdj.2008.32.1.30 · Cited by 2
Shuumarjav, U., Kotani, K., Taniguchi, N., Matsunaga, H., Kanai, H., Hasegawa, H., Kario, K., Ishibashi, S., & Itoh, K. (2009) · Journal of Medical Ultrasonics · doi:10.1007/s10396-009-0217-3 · Cited by 3
Associations Between Heart Rate Variability and Metabolic Syndrome Risk Factors
Stuckey, M. I. (2013) · Scholarship@Western (Western University) · Cited by 2
Docherty, P. D., Chase, J. G., Morenga, L. T., & Fisk, L. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814536511 · Cited by 2
Li, D., Hou, X., Ma, X., et al. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03350.x · Cited by 2
van der Zijl, N. J., Muskiet, M. H. A., Tushuizen, M. E., Rijzewijk, L. J., Schindhelm, R. K., Moors, C. C. M., Goossens, G. H., Blaak, E. E., Pouwels, P. J. W., & Diamant, M. (2010) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2010.05.018 · Cited by 2
Mahfouz (2011) · American journal of biochemistry & biotechnology/American journal of biochemistry and biotechnology · doi:10.3844/ajbbsp.2011.63.69 · Cited by 2
Henry, O., Vaysse, C., Lopez, C., Driss, F., Fonseca, I., Simon, N., Guillou, C. L., Masselin‐Silvin, S., David, J., Combe, N., et al. (2015) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.201500213 · Cited by 1
Huang, L., Chen, I.-J., & Hsu, C.-H. (2015) · Journal of Traditional and Complementary Medicine · doi:10.1016/j.jtcme.2015.10.003 · Cited by 2
Nathanielsz, P. W., Choi, J., Li, C., McDonald, T. J., Comuzzie, A. G., & Mattern, V. L. (2011) · Cited by 2
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
